Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis

about

Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis

Item

http://www.wikidata.org/entity/Q37408595

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Therapeutic efficacy and safet ...... reatic cancer: a meta-analysis

@en

Therapeutic efficacy and safet ...... eatic cancer: a meta-analysis.

@nl

type

Item

label

Therapeutic efficacy and safet ...... reatic cancer: a meta-analysis

@en

Therapeutic efficacy and safet ...... eatic cancer: a meta-analysis.

@nl

prefLabel

Therapeutic efficacy and safet ...... reatic cancer: a meta-analysis

@en

Therapeutic efficacy and safet ...... eatic cancer: a meta-analysis.

@nl

P1476

Therapeutic efficacy and safet ...... reatic cancer: a meta-analysis

@en

P2093

Bingjie Ju

http://www.w3.org/2001/XMLSchema#string

Dongkai Zhou

http://www.w3.org/2001/XMLSchema#string

Haiyang Xie

http://www.w3.org/2001/XMLSchema#string

Lin Zhou

http://www.w3.org/2001/XMLSchema#string

Qifan Yang

http://www.w3.org/2001/XMLSchema#string

Shusen Zheng

http://www.w3.org/2001/XMLSchema#string

Sinan Lu

http://www.w3.org/2001/XMLSchema#string

Weilin Wang

http://www.w3.org/2001/XMLSchema#string

Xiaohu Zhou

http://www.w3.org/2001/XMLSchema#string

Xinyi Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Global cancer statistics, 2012

Cancer statistics, 2016

Aggregate data meta-analysis with time-to-event outcomes.

The addition of S-1 to gemcitabine-based chemotherapy improves survival with increased toxicity for patients with advanced pancreatic cancer: combined meta-analysis of efficacy and safety profile.

Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer.

Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.

S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancreatic cancer: a randomized, open-label, multicenter, phase II study

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

P2888

srep36944

P304

36944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1038/SREP36944

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27833144

http://www.w3.org/2001/XMLSchema#string

P932

5105146

http://www.w3.org/2001/XMLSchema#string